For the quarter ending 2026-03-31, LIDRW had $1,806K increase in cash & cash equivalents over the period. -$8,742K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -8,345 | -7,342 | -9,330 | -17,286 |
| Depreciation and amortization | 40 | 42 | 38 | 75 |
| Expected credit losses, net of write-off | - | 0 | 0 | 2 |
| Gain on sale of property and equipment, net | - | 0 | 0 | - |
| Noncash lease expense relating to operating lease right-of-use assets | 75 | 54 | 54 | 103 |
| Gain on termination of operating lease, net | 0 | 0 | -598 | 1,612 |
| Common stock purchase agreement costs | 136 | 12 | 19 | 306 |
| Debt issuance costs | 0 | 0 | 0 | 2,020 |
| Gain on extinguishment of warrant | - | 0 | 64 | - |
| Inventory write-downs, net of scrapped inventory | 0 | 24 | 0 | 24 |
| Change in fair value of convertible note and warrant liabilities | 19 | 228 | -2,210 | 87 |
| Stock-based compensation | 1,542 | 790 | 1,071 | 3,661 |
| Amortization of premiums and accretion of discounts on marketable securities, net of change in accrued interest | -57 | 198 | 23 | 157 |
| Accounts receivable, net | 19 | 21 | 29 | 18 |
| Inventories, current and noncurrent, net | -52 | 155 | 409 | 114 |
| Prepaid and other current assets | -684 | 1,146 | -8 | -84 |
| Contract liabilities | - | - | 0 | 0 |
| Other noncurrent liabilities | - | 0 | 0 | 0 |
| Other noncurrent assets | -53 | -54 | -53 | -134 |
| Accounts payable | 205 | -791 | -961 | 1,761 |
| Accrued expenses and other current liabilities | -2,895 | 37 | 718 | -1,522 |
| Operating lease liabilities | -121 | 1,338 | -42 | -1,532 |
| Net cash used in operating activities | -8,555 | -7,530 | -6,089 | -14,158 |
| Purchases of property and equipment | 187 | 57 | 38 | 14 |
| Proceeds from sale of property and equipment | - | 0 | 0 | - |
| Purchases of marketable securities | 0 | 8,779 | 30,686 | 14,303 |
| Proceeds from redemptions and maturities of marketable securities | 10,900 | 7,205 | 6,243 | 9,631 |
| Net cash provided by (used in) investing activities | 10,713 | -1,631 | -24,481 | -4,686 |
| Payments for convertible note redemptions | - | 0 | 239 | 750 |
| Proceeds from exercise of warrant | - | 0 | 1,788 | - |
| Proceeds from issuance of common stock through the employee stock purchase plan | - | 39 | 0 | 52 |
| Proceeds from exercise of stock options | - | 0 | 0 | 0 |
| Proceeds from issuance of convertible note | 0 | 0 | 0 | 2,950 |
| Transaction costs related to issuance of convertible note | 0 | 0 | 50 | 608 |
| Proceeds from issuance of common stock under common stock purchase agreements | 0 | 9,973 | 70,912 | 10,076 |
| Stock issuance costs related to common stock purchase agreements | 100 | 386 | 1,045 | 404 |
| Taxes paid related to the net share settlement of equity awards | 252 | 144 | 135 | 364 |
| Net cash provided by (used in) financing activities | -352 | 9,482 | 71,231 | 10,952 |
| Net increase (decrease) in cash and cash equivalents | 1,806 | 321 | 40,661 | -7,892 |
| Cash and cash equivalentsbeginning of period | 43,356 | -32,769 | 10,266 | - |
| Cash and cash equivalentsend of period | 45,162 | 321 | 43,035 | - |
AEye, Inc. (LIDRW)
AEye, Inc. (LIDRW)